Literature DB >> 20443975

Genetic analysis of LRRK2 functional domains in Brazilian patients with Parkinson's disease.

C B Abdalla-Carvalho1, C B Santos-Rebouças, B C Guimarães, M Campos, J S Pereira, A L Zuma de Rosso, D H Nicaretta, M Marinho e Silva, Mendonça J dos Santos, M M G Pimentel.   

Abstract

BACKGROUND AND
PURPOSE: Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been associated with Parkinson's disease (PD), and the majority of the pathogenic variants are located in the ROC and MAPKKK domains.
METHODS: Exons 29-31 and 38-44 (ROC and MAPKKK domains) were sequenced in 204 patients with PD, mostly Brazilian.
RESULTS: We identified four polymorphisms, a novel silent variant p.R1398R and four substitutions: p.T1410M, p.G2019S, p.Y2189C and the novel variant p.C2139S.
CONCLUSIONS: The most prevalent mutation was the p.G2019S (2.4%). We consider that the p.T1410M and the p.Y2189C variants are probably polymorphisms and that the p.C2139S mutation is potentially pathogenic.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20443975     DOI: 10.1111/j.1468-1331.2010.03039.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  5 in total

1.  Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

Authors:  Min Liu; Samantha A Bender; Gregory D Cuny; Woody Sherman; Marcie Glicksman; Soumya S Ray
Journal:  Biochemistry       Date:  2013-03-01       Impact factor: 3.162

2.  Evaluating LRRK2 genetic variants with unclear pathogenicity.

Authors:  Fathima Shaffra Refai; Shin Hui Ng; Eng-King Tan
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

3.  Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Authors:  Mario Cornejo-Olivas; Luis Torres; Mario R Velit-Salazar; Miguel Inca-Martinez; Pilar Mazzetti; Carlos Cosentino; Federico Micheli; Claudia Perandones; Elena Dieguez; Victor Raggio; Vitor Tumas; Vanderci Borges; Henrique B Ferraz; Carlos R M Rieder; Artur Shumacher-Schuh; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Francisco Lopera; Jorge Chang-Castello; Brennie Andreé-Munoz; Sarah Waldherr; Dora Yearout; Cyrus P Zabetian; Ignacio F Mata
Journal:  NPJ Parkinsons Dis       Date:  2017-06-02

4.  The LRRK2 signaling network converges on a centriolar phospho-Rab10/RILPL1 complex to cause deficits in centrosome cohesion and cell polarization.

Authors:  Antonio Jesús Lara Ordóñez; Rachel Fasiczka; Belén Fernández; Yahaira Naaldijk; Elena Fdez; Marian Blanca Ramírez; Sébastien Phan; Daniela Boassa; Sabine Hilfiker
Journal:  Biol Open       Date:  2022-07-29       Impact factor: 2.643

Review 5.  Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease.

Authors:  Laura J Smith; Chiao-Yin Lee; Elisa Menozzi; Anthony H V Schapira
Journal:  Front Neurol       Date:  2022-08-12       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.